GlassScriptPhysician profile
Beth Ann White
NPI 1598724353
$1,756.34
in general payments reported to CMS, 2019-2025
11 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $252 · 2023: $625 · 2024: $434 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $328.73 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $321.81 | 2022-2024 | Wainua, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $275.03 | 2022-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $214.52 | 2023 | |
| Cvrx, INC. | $198.74 | 2023 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.13 | 2022 | |
| Abbott Laboratories | $106.79 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $78.55 | 2023 | |
| Novo Nordisk INC | $72.82 | 2024-2025 | Wegovy, Ozempic |
| Lantheus Medical Imaging, INC. | $36.55 | 2023 | Definity |
| Pfizer INC. | $14.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.